Beconase and Atacand drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Beconase and Atacand. Common interactions include confusional state among females and renal failure acute among males.

The phase IV clinical study analyzes what interactions people who take Beconase and Atacand have. It is created by eHealthMe based on reports of 7 people who take Beconase and Atacand from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Mar, 18, 2023

7 people who take Beconase and Atacand together, and have interactions are studied.


What is Beconase?

Beconase has active ingredients of beclomethasone dipropionate. It is often used in asthma. eHealthMe is studying from 1,215 Beconase users for its effectiveness, alternative drugs and more.

What is Atacand?

Atacand has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 21,793 Atacand users for its effectiveness, alternative drugs and more.

Number of Beconase and Atacand reports submitted per year:

Beconase and Atacand drug interactions.

Common Beconase and Atacand drug interactions by gender *:

female:

  1. Confusional state
  2. Dermatitis medicamentosa
  3. Dystonia
  4. Hypokinesia
  5. Listless
  6. Muscle rigidity
  7. Muscle spasms
  8. Neutrophil count increased
  9. Pyrexia
  10. Tremor

male:

  1. Renal failure acute
  2. Dehydration
  3. Fatigue
  4. Hepatic steatosis
  5. Hepatomegaly
  6. Hypotension
  7. Insomnia
  8. Lung infection
  9. Muscle spasms
  10. Musculoskeletal discomfort

Common Beconase and Atacand drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Renal failure acute
  2. Dehydration
  3. Depression
  4. Dermatitis medicamentosa
  5. Dystonia
  6. Fatigue
  7. Hepatic steatosis
  8. Hepatomegaly
  9. Hypokinesia
  10. Hypotension

* Approximation only. Some reports may have incomplete information.

Do you take Beconase and Atacand?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Beconase and Atacand:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Atacand side effects:

Browse all side effects of Atacand:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Beconase interactions:

Browse all interactions between Beconase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Atacand interactions:

Browse all interactions between Atacand and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on beclomethasone dipropionate and candesartan cilexetil (the active ingredients of Beconase and Atacand, respectively), and Beconase and Atacand (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Beconase and Atacand.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: